Joseph M. Feczko, Director at KERYX BIOPHARMACEUTICALS INC (KERX), bought 20,000 shares at $4.34 ($87K) on 2011-03-22, disclosed to the SEC on 2011-03-22.
Open-market purchase of $87k KERX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| KERX | BUY | 2011-08-11 | $31K | — | Filing → |
| PFE | SELL | 2007-04-25 | $561K | — | Filing → |
| PFE | SELL | 2007-02-15 | $1.8M | — | Filing → |